<DOC>
	<DOCNO>NCT02251145</DOCNO>
	<brief_summary>Study characterise effect two dose combination tipranavir/ritonavir ( TPV 500 mg/RTV 100 mg TPV 750 mg/RTV 200 mg ) administer BID , pharmacokinetics tenofovir disoproxil fumarate well effect tenofovir disoproxil fumarate pharmacokinetics tipranavir/ritonavir .</brief_summary>
	<brief_title>Effects Tipranavir ( TPV ) Ritonavir ( RTV ) Pharmacokinetic Characteristics Tenofovir Disoproxil Fumarate Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<criteria>1 . Ability willingness give write informed consent accordance institutional regulatory guideline comply investigational nature study relate requirement 2 . Healthy male females 18 60 year age inclusive 3 . A Body Mass Index &gt; 18.5 &lt; 30 kg/m2 4 . Ability swallow numerous large capsule without difficulty 5 . Reasonable probability completion study , opinion investigator 6 . Acceptable laboratory value indicate adequate baseline organ function require time screen . Laboratory value consider acceptable severity &lt; = Grade1 base AIDS Clinical Trials Group ( ACTG ) Division AIDS ( DAIDS ) Grading Scale . All abnormal laboratory value &gt; Grade 1 ( e.g. , creatine phosphokinase ( CPK ) , amylase , triglyceride ) subject approval BIPI clinical monitor . Cholesterol &lt; = 240mg/dL time screen necessary study entry 7 . Acceptable medical history , physical examination ECG require prior enter study 8 . Willingness abstain alcohol 48 hour prior Study Day 0 abstain alcohol duration study . In addition , Cabernet Sauvignon must ingest within 15 day prior Day 0 ( Visit 2 ) 9 . Willingness abstain ingest grapefruit grapefruit juice within 15 day Day 0 , Visit 2 duration study 10 . Willingness abstain ingest Seville orange , strawberry strawberry extract , garlic supplement , St. John 's Wort , Milk Thistle , methylxanthinecontaining drink food ( coffee , tea , cola , energy drink , chocolate , etc ) within 72 hour pharmacokinetic ( PK ) sample day 11 . Willingness abstain use tobacco product duration study 12 . Urine drug screen negative illegal nonprescription drug 13 . Negative HIV serology 14 . Negative Hepatitis B surface antigen Hepatitis C 1 . Female subject reproductive potential : Have positive serum BHCG Visit 1 2 Have use regular oral contraception ( combine oestrogen progestogen pill progestogen pill ) 3 month barrier contraceptive method least 30 day prior Visit 3 ( Day 1 ) barrier contraceptive method least 3 month prior Visit 3 ( Day 1 ) Are willing use reliable method doublebarrier contraception ( diaphragm spermicidal cream/jelly condoms spermicidal foam ) trial 30 day completion/termination Are breastfeed 2 . Participation another trial investigational medicine 30 day prior Day 0 ( Visit 2 ) 3 . Ingestion know enzyme alter drug ( phenothiazine , cimetidine , barbiturate , ketoconazole , fluconazole , rifampin , steroid , herbal medication ) 30 day prior Day 0 ( Visit 2 ) . Use herbal/complementary treatment must discuss advance monitor permission obtain prior study entry 4 . Ingestion grapefruit , grapefruit juice , Cabernet Sauvignon within 15 day prior Day 0 ( Visit 2 ) 5 . Ingestion Seville orange , strawberry strawberry extract , garlic supplement , St. John 's Wort , Milk Thistle , methylxanthinecontaining drink food ( coffee , tea , cola , energy drink , chocolate , etc ) within 72 hour PK sample day 6 . Ingestion antibiotic within 10 day prior Day 0 ( Visit 2 ) 7 . Inability comply investigator 's instruction 8 . History gastrointestinal , hepatic , renal disorder within 60 day 9 . History alcohol abuse 10 . Current use cigarette define great 10 cigarette per day rolling/pipe tobacco equivalent 11 . Blood plasma donation within 30 day prior Day 0 ( Visit 2 ) 12 . Subjects seat systolic blood pressure either &lt; 100 mm Hg &gt; 150 mm Hg ; rest heart rate either &lt; 50 beats/min &gt; 100 beats/min 13 . Subjects history illness allergy , opinion investigator , might confound result study pose additional risk administer tipranavir ritonavir tenofovir disoproxil fumarate subject 14 . Subjects acute illness within 2 week prior Day 0 ( Visit 2 ) 15 . Subjects currently take overthecounter drug within 7 day prior Day 0 , ( Visit 2 ) currently take prescription drug , opinion investigator consultation clinical monitor pharmacokineticist , might interfere either absorption , distribution metabolism test substances 16 . Hypersensitivity tipranavir , ritonavir , tenofovir disoproxil fumarate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>